Market Research Logo

United Kingdom Pharmaceuticals & Healthcare Q1 2020

United Kingdom Pharmaceuticals & Healthcare Q1 2020

Key View:

The outlook for the UK market is polarised by factors relating to Brexit outcomes. In the softer Brexit scenarios, themaintenance of regulatory and customs alignment with the EU will preclude any major disruption to supply chains, pharmaceuticallicenses and NHS staffing. However, in harder Brexit scenarios including a ‘no-deal Brexit’, disruption at short-strait border crossingswould impact supply to the UK market. We note that a ‘no-deal’ Brexit remains a possibility although with a diminishing likelihood.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Western Europe Innovative Pharmaceuticals Risk/Reward Index
Industry Risk/Reward Index
Regulatory Development
Market Overview
Competitive Landscape
Company Profile
AstraZeneca
GlaxoSmithKline
Novartis
Pfizer
Sanofi
United Kingdom Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook